Tocilizumab

Details

Files

Generic Name:

Tocilizumab

Project Status:

Complete

Therapeutic Area:

Arthritis, polyarticular juvenile idiopathic

Manufacturer:

Hoffmann-La Roche Limited

Call for patient/clinician input open:

July 8, 2013

Brand Name:

Actemra

Project Line:

Reimbursement Review

Project Number:

SR0343-000

Call for patient/clinician input closed:

August 12, 2013

NOC Status at Filing:

Pre NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Polyarticular juvenile idiopathic arthritis

Recommendation Type:

List with criteria/condition

Final Recommendation:

March 19, 2014

Files

Submission Status Report View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Recommendation and Reasons View PDF

Last Updated : July 29, 2013